Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Commentary
Editorial
Guest Editorial
Letter to Editor
Letter to the Editor
Media and News
Medical Innovator
Mini-Review
Original Article
Review Article
Short Communication
View/Download PDF

Translate this page into:

Review Article
2023
:18;
24
doi:
10.25259/GJMPBU_154_2022

Efficacy of Plant Extracts against Carbapenem Resistant Acinetobacter baumannii: A Notorious Pathogen in the Intensive Care Unit

, ,
1Department of Medical Microbiology, Centre for Interdisciplinary Biomedical Research, Adesh University, Bathinda, Punjab, India
2Department of Surgery, Adesh Institute of Medical Sciences and Research Centre, Adesh Hospital, Bathinda, Punjab, India
3Department of Surgical Gastroenterology, Nishtha Surgical Hospital and Research Center, Patan, India
4Department of Surgery, Banas Medical College and Research Institute, Palanpur, Gujarat, India
*Corresponding author: Manita Paneri, Department of Medical Microbiology, Centre for Interdisciplinary Biomedical Research, Adesh University, Bathinda, Punjab, India. manitaprashant@gmail.com
Received: , Accepted: ,
© 2023 Published by Scientific Scholar on behalf of Global Journal of Medical, Pharmaceutical, and Biomedical Update
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Paneri M, Sevta P, Yagnik VD. Efficacy of plant extracts against carbapenem resistant Acinetobacter baumannii: A notorious pathogen in the intensive care unit. Glob J Med Pharm Biomed Update 2023;18:24.

Abstract

Carbapenem was originally regarded as a cornerstone therapeutic for Gram-negative bacterial infections that could be fatal, but these pathogens are rapidly acquiring resistance to it by various methods such as forming biofilms, mutations in porin channels, overexpression of efflux pumps, altering or modifying antibiotics, and by horizontal gene transfer of resistance biomarkers. Among Gram-negative pathogens, the World Health Organization has prioritized Acinetobacter baumannii as a “pathogen of concern.” A. baumannii strains have a variety of antibiotics resistance pathways, making them resistant to the majority of antibiotics. Antibiotics are used indiscriminately and excessively, causing extensive natural selection pressure and allowing just the most versatile variants of A. baumannii to flourish. Evolutionary changes are unavoidable, but the widespread utilization of antimicrobials in communities, hospitals, and agriculture industries is certainly contributing to the outbreak. Antibiotic resistance has resulted in a number of adverse outcomes such as inadequacy of antimicrobials, persistent infections, and physical ailments that cause the patients to lose momentum, longer stay in the hospital, increased mortality, and morbidity, as well as increased cost that can overburden the patients and even the hospitals. Therefore, optimizing efficient alternate natural antibacterial compounds is a critical aspect of addressing the problem of antibiotic resistance. Various studies (in vitro) done by scientists and researchers have illustrated the efficacy of plant extracts and their essential oils against A. baumannii and other pathogens. The most urgent need is to do research in vivo and more screening of natural products or plant parts, which might lead to the discovery of novel therapeutically efficient antibacterial agents against resistant bacterial infections.

Keywords

Antibiotic resistance
Acinetobacter baumannii
Plant extracts
Essential oils
Carbapenem resistance

INTRODUCTION

Antibiotic resistance is one of the most critical matters confronting the clinical and industrial sectors, as well as the environment and social development. Antimicrobials are used excessively or unrestrictedly in humans and animals, which is really the leading cause of antibiotic resistance.[1] Acinetobacter baumannii, a non-fermenting member of the Moraxellaceae family, is the prominent bacterium that is responsible for hospital acquired diseases because it possesses various resistance mechanisms, such as the production of beta-lactamases, porin channel loss, reduced membrane permeability, modified antibiotic binding positions, and overexpression of efflux pumps[2] [Figure 1].

Figure 1:
Resistance mechanism of Bacteria.

A. baumannii may be found in the soil and water, as well as on the skin of healthy individuals.[3] Patients who are on ventilators, have devices such as enteral feeding tubes and catheters, have open wounds postoperatively, are in intensive care units (ICUs), are immunocompromised, unconscious, have a history of taking certain antibiotics for prolonged period of time, or have protracted hospital stays are at risk for getting infection from this pathogen.[4] A. baumannii can also have the ability to use ethanol as a carbon source and survive desiccation.[5]

Multidrug resistance (MDR) A. baumannii infections are a significant concern in those patients who are hospitalized in the ICU.[6] It causes bloodstream infections, skin and soft-tissue infections, ventilator-associated pneumonia, urinary tract infections, meningitis, and endocarditis.[7] Inappropriate management and restricted therapeutic alternatives are responsible for poor outcomes and these infections are linked to high fatality rates, particularly among ICU patients.[8]

Carbapenems such as doripenem, imipenem, ertapenem, and meropenem are antibiotics used as the last option to treat diseases caused by MDR A. baumannii.[9] Carbapenem-resistant isolates, on the other hand, are appearing at an alarming rate through producing carbapenamase enzymes (Metallo-lactamases and Oxacillinases) that possess the ability to hydrolyze these antibiotics.[9-11]

Most existing treatment options, including carbapenems or combination antibiotic therapy, are futile because of A. baumannii immense adaptive capability to withstand the harsh environment and acquiring and disseminating antibiotic resistant genes through intrinsic or horizontal gene transfer. A. baumannii is the primary pathogen on the World Health Organization’s priority list for novel antibiotic research.[11-14]

Cross-infection between patients and inter/intraspecies transfer of resistance components is more likely when infection control methods are breached.[15] Furthermore, A. baumannii has a substantial capability to produce biofilms on a different type of surfaces, which not only boosts A. baumannii’s potential for nosocomial dissemination but also enhances antibiotic resilience and pathogenicity[16] [Figure 2].[2]

Figure 2:
Biofilm Formation.

Colistin is currently thought to be the only medicine that has the potential to treat infections spurred by carbapenem-resistant A. baumannii;[11,17,18] Nevertheless, strains resistant to this antibiotic are also being identified.[19] Therefore, innovative new methods and drugs for treating A. baumannii infection are urgently required.

For many years, humanity has suffered the effects of a plethora of infection and disease-causing microorganisms. Extensive research projects have been carried out to analyze the usefulness of the plant extracts and active compounds in combating the problem of antimicrobial resistance in bacteria.[20] Plant extracts, which are complex combinations of main chemicals and their secondary metabolites, may have synergistic effects with conventional antibiotics.[21] Natural products have several advantages over synthetic antimicrobial chemicals, including fewer side effects, improved patient tolerance, low cost, wide acceptability due to traditional usage, renewability, and superior biodegradability.[22]

In various research studies, the following plant extracts and their essential oils are being used to combat A. baumannii infections: [Table 1]

Table 1: Plant extracts and essential oils against Acinetobacter baumannii.

Cinnamomum zeylanicum (CINNAMON)

Cinnamon has been utilized since 2000 BC in Ancient Egypt, when it was highly valued. It was used by doctors in mediaeval times to alleviate arthritis, coughing, and sore throats.[23] Cinnamon is mostly made up of essential oils and compounds such as cinnamic acid, cinnamaldehyde, and cinnamate.[24] Cinnamon has an anticancer, anti-inflammatory, antimicrobial, anti-diabetic, cardiovascular-disease-lowering, and lipid lowering capabilities.[25]

Cinnamomum verum is a tiny, evergreen Lauraceae family tree which is often recognized as a “real cinnamon tree” and “Ceylon cinnamon tree.” The bark of cinnamon trees, such as Cinnamomum cassia, C. verum, and other species, is used to make cinnamon.[26,27] This tree’s botanical name, C. zeylanicum, originates from “Ceylon,” the historic name for Sri Lanka.[27] C. cassia, popularly known as “Chinese cinnamon,” is an evergreen tree that is native to South China.[28]

The main components of Cinnamon and its essential oils are cinnamaldehyde, caryophyllene, eugenol, and linalool.[29] Cinnamon also contains essential components such as cinnamyl acetate, procyanidin-A and methyl cinnamate.[30] Essential oils and their secondary metabolites have been utilized as bactericides, insecticides, antiseptic, and fungicides since the middle ages. According to Morais et al., 2019 these components are often employed in the food and pharmaceutical sectors, as well as in cosmetics and medical devices manufacturing industries due to their diverse qualities.[31]

Cinnamon essential oil has antibacterial activity against antibiotic resistant pathogens such as methicillin resistant Staphylococcus aureus, A. baumannii, Pseudomonas aeruginosa, and vancomycin resistant Enterococcus faecium.[32] Essential oils have the capacity to limit bacterial multiplication and can minimize the required active concentration of antibiotics due to their synergistic effect. “Synergy” is defined as “when the combined impact is greater than the sum of the individual effect in combination treatment.” Combined effect, that is equal to the sum of all the individual impacts, has an additive effect.

Guerra et al., 2012 demonstrated that essential oils from C. zeylanicum and Citrus limon combined with amikacin had a synergistic impact against A. baumannii strains.[33,34] Essential oils are typically extracted using steam distillation or mechanical expression whereas plant extracts are commonly extracted using acetone, ethanol, or hexane.[35] Water condensate is separated from essential oil during distillation procedure through gravity, releasing a very little amount of volatile fluid. Essential oils may be able to advance from being traditional agents to being the commonly utilized therapy in the modern medical domain in the future[22] [Figure 3].

Figure 3:
Distillation process of Cinnamomum zeylanicum (Cinnamon).

According to Karumathil et al., 2018 transcinnamaldehyde in combination with antibiotics enhanced A. baumannii susceptibility to lactam antibiotics such as penicillin, ampicillin, amoxicillin, piperacillin, methicillin, meropenem, and aztreonam.[36]

Sienkiewicz et al., 2014 assessed in their research study that all A. baumannii isolates obtained from medical devices and the environment with a degree of resistance, have shown to be inhibited by the essential oils.[34]

Thirapanmethee et al. 2021 demonstrated in their study that cinnamaldehyde displayed significant antimicrobial activity against all clinical strains in dose dependent approach, and it had no negative impact on the susceptibility of A. baumannii to any of the antimicrobials examined. Cinnamaldehyde had very low minimum inhibitory concentration (MIC) of 0.01–0.04% (v/v), and it had showed a minimum bactericidal concentration (MBC) that were equivalent to the MICs against most MDR A. baumannii strains. After treatment with cinnamaldehyde, the bacterial cells continued to elongate and cell separation was interrupted.[37]

Cinnamaldehyde’s antibacterial effect has lately been researched and a mechanism such as interaction with the cell membrane and fast suppression of energy metabolism has been proposed. Because of its hydrophobicity, it can infiltrate and disrupt the lipid bilayer of the cell membrane causing greater permeability to protons and the evacuation of essential chemicals and ions from bacterial cells, eventually leading to lysis of bacterial cells.

Mohamed et al. (2018) showed in their research study that low concentrations of cinnamaldehyde had excellent antibacterial and antibiofilm action against A. baumannii clinical strains that produce robust biofilms, with MIC and MBC of 0.875 and 1.75 mg/mL, respectively. Hence, they suggested that it might be utilized to treat biofilm-related clinical issues caused by this pathogen.[38]

Cinnamaldehyde decreases quorum sensing (QS) signaling at a specific concentration, which leads to a reduction of extracellular polymer production, which may also explain its powerful antibiofilm effect.[39]

Sabir and Sidiq demonstrated that when cinnamon nanoemulsions are combined with either kanamycin or gentamycin, the antibacterial activity of both antibiotics is significantly increased compared to when they are used alone. As a result, a combination like this might be utilized to combat MDR A. baumannii.[40]

Zingiber officinale roscoe (GINGER)

Ginger (Z. officinale Roscoe) is a popular spice from the Zingiberaceae family that is grown all over the world, but particularly in Asian nations.[41] Ginger’s rhizome contains a unique homologous set of molecules known as Gingerols, which are the main phenolic plant’s secondary metabolites, responsible for the spice’s distinct flavor and health benefits.[42] Research projects have been undertaken widely over the last two decades to uncover bioactive components and the therapeutic efficiency of ginger.[43] Ginger’s antibacterial, anti-inflammatory, blood pressure-lowering, cholesterol-lowering, antiplatelet aggregation, chemo preventive, antioxidant, and hypoglycemic characteristics are all possible health advantages.[44]

According to Wang et al. (2010) four known component of ginger, 6-dehydrogingerdione, 6-shogaol, 10-gingerol, and 6-gingerol have been shown to have antimicrobial properties against extensively drug resistant A. baumannii (XDRAB). Their findings suggest that ginger compounds have antioxidant properties that can aid in antibacterial action and therefore could be used to treat XDRAB infections.[45]

Al Meani et al. (2020) in their research study observed that the effects of ginger volatile oil on carbapenamase production and carbapenamase activity were both positive. When used with the checkerboard approach with meropenem, ginger volatile oil had a synergistic impact against A. baumannii.[46]

Coriander sativum (CORIANDER)

Coriander (C. sativum L.) belongs to the Apiaceae family and is used worldwide as medicinal herb with nutritional and therapeutic properties. The antibacterial, anticancer, antioxidant, antidiabetic, free radical, and antimutagenic properties of coriander extracts and essential oils have been demonstrated.[47] Although all parts of the coriander plant are edible, their flavors and applications may differ. The aerial parts of C. sativum have been the subject of most reported findings on antioxidant activity.[48]

Microdilution susceptibility tests and checkerboard assays were used to examine coriander oil’s antibacterial activity and synergistic interaction by Duarte et al. (2012) and antibiotics such as chloramphenicol, tetracycline, piperacillin ciprofloxacin, gentamicin, and cefoperazone were found to have synergistic or additive action with coriander oil against A. baumannii.[49]

Alves et al. (2016) evaluated the effectiveness of linalool on planktonic cells and biofilm of A. baumannii on different substrates. They also examined its effect on adherence and QS and they found that linalool had the greatest bactericidal activity of all the chemicals tested, with MICs ranging between 2 and 8 μL/mL. Linalool also inhibited the production of A. baumannii biofilms, dispersed existing biofilms, altered A. baumannii adherence to substrates, and hindered the quorum-sensing system.[50]

Aegle marmelos (BAEL)

A. marmelos (Family Rutaceae), also called as “Bael” in Bengal and “Vilvam” in Tamil, is found in arid woods across India and is also farmed.[51] The blooms are greenish white, the leaves are trifoliate, the bark is yellowish brown, and the fruits are green with orange brown tasty sticky pulps. Asthma, emphysema, diarrhea, dysentery, dyspepsia, stomach discomfort, seminal weakness, uropathy, vomiting, diabetes, snake bite, seafood poisoning, and certain antiviral activity are all treated with extracts from various portions of the plant.[52]

Bael or A. marmelos contains steroid, tannin, terpenoids, phenol, glycoside, coumarin, alkaloids, and quinones, when combined with imipenem, Bael is particularly effective against A. baumannii strains (ATCC19606 which was carbapenem susceptible, and RS 307 which was resistant to carbapenem). However, it has a lower inhibitory impact when used alone. Antibiotics alone had a modest inhibition zone, but when combined with herbal extracts, they had a wider inhibition zone.[53]

Actinidia deliciosa (KIWI)

Tiwari et al. (2017) discovered the anti-biofilm activity in aqueous extracts of A. deliciosa (Kiwi) and Syzygium aromaticum (clove) against A. baumannii.[54,55] Sanquinarine (alkaloid) as well as hydroxyflavone (flavonoid) are found in A. deliciosa extract. The anti-biofilm action of these extracts on A. baumannii extracellular matrix (ECM) revealed that it lowers the levels of exopolysaccharides, proteins, and extracellular deoxyribose nucleic acid in the ECM.

Origanum vulgare (OREGANO)

Oregano (family-Lamiaceae) is a perennial plant which is native to the Mediterranean and Euro/Irano-Siberian Mountain ranges. Dried Oregano leaves are commonly utilized as a culinary herb in Italian cuisine, but they are also included in traditional medicine to cure indigestion, colds, and upset stomach due to the high carvacrol and thymol content naturally present in its essential oil.[56]

Microdilution (Resazurin Microtiter Assay), Time kill test, and Disk diffusion test were used to evaluate the antibacterial potential of O. vulgare L. essential oil (OVeo) to encounter carbapenem-resistant microorganisms by Vasconcelos et al. (2019) and found that O. vulgare essential oil has significant antibacterial action against MDR A. baumannii. They discovered that OVeo exhibited MIC of 0.015% (v/v) for A. baumannii.[57]

Another research work was done by Amaral et al. (2020), in which they evaluated the combination of Oregano essential oil (OEO) and polymyxin against MDR A. baumannii and found that carvacrol (71.0%) was the most common component of OEO, followed by –caryophyllene (4.0%), γ-terpinene (4.5%), p-cymene (3.5%), and thymol (3.0%). With MICs ranging from 1.75 to 3.50 mg/mL, OEO showed antibacterial activity against all A. baumannii-MDR strains. Flow cytometry revealed that the OEO promotes bacterial cell membrane instability and rupture, resulting in the death of A. baumannii cells. A checkerboard experiment revealed a synergic relationship between OEO and polymyxin B. When used together, OEO resulted in a 16-fold decrease in polymyxin B MIC. The findings suggest that using OEO alone or in combination with polymyxin B to treat A. baumannii MDR infections is a potential option.[58]

Eucalyptus camaldulensis (RED RIVER GUM)

E. camaldulensis (red river gum) is a species of the Eucalyptus genus, which belongs to the Myrtaceae family, and includes over 900 species. E. camaldulensis essential oils and extracts are found to be most active against pathogens when they were compared with other species of genus Eucalyptus.

Knezevic et al. (2016) demonstrated that terpinen-4-ol, spatulenol, p-cimene, 1, 8-cineole, cryptone, and β-pinene were the most prominent components in E. camaldulensis essential oils. The MICs for E. camaldulensis essential oils were found to be in the range of 0.5–2 μL/mL. Time-kill curves for E. camaldulensis essential oils with polymyxin B lowered bacterial count under detection limit which was incredibly fast, that is, after 6 hrs of incubation, confirming the synergistic interaction.[59] In most cases, the studied essential oils had a synergistic antibacterial effect when they are used with traditional antibiotics such as polymyxin, ciprofloxacin, gentamicin, and in some situations, they even resensitized MDR A. baumannii isolates.

CONCLUSION

Antibiotic resistance in pathogenic microorganisms has sparked research attempts to find new medicines and produce efficient derivatives of already existing antibiotics because of the rapid growth of antibiotic resistance in pathogenic microbes, particularly to multiple prescribed drugs. However, no new antibiotics are being developed. Hence, plant extracts can be utilized for the benefit of human health as an alternative to therapeutic drugs and as an antibacterial supplement in health-care services that could cut costs while being safe. Yet, further research is needed, such as in vivo toxicity studies and clinical trials, to evaluate the efficacy of plant extracts.

Declaration of patient consent

Patient’s consent not required as there are no patients in this study.

Conflicts of interest

There are no conflicts of interest.

Financial support and sponsorship

Nil.

References

  1. , . Dysbiosis of gut microbiota in patients undergoing cardiac surgery. Glob J Med Pharm Biomed Update. 2022;17:13.
    [CrossRef] [Google Scholar]
  2. , . Overview of antimicrobial resistance: An emerging silent pandemic. Glob J Med Pharm Biomed Update. 2023;18:11.
    [CrossRef] [Google Scholar]
  3. , , . Insight into Acinetobacter baumannii Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018;11:1249-60.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , . Risk factors and drug resistance of the MDR Acinetobacter baumannii in pneumonia patients in ICU. Open Med (Wars). 2019;14:772-7.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , , , et al. Desiccation and ethanol resistances of multidrug resistant Acinetobacter baumannii embedded in biofilm: The favorable antiseptic efficacy of combination chlorhexidine gluconate and ethanol. J Microbiol Immunol Infect. 2018;51:770-7.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , , et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: A review. Infect Drug Resist. 2021;14:3711-9.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , , , , , et al. Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii A case-control study. Diagn Microbiol Infect Dis. 2021;99:115229.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , , , et al. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2022;50:83-92.
    [CrossRef] [PubMed] [Google Scholar]
  9. , . Carbapenem resistance in Acinetobacter baumannii and their importance in hospital-acquired infections: A scientific review. J Appl Microbiol. 2021;131:2715-38.
    [CrossRef] [PubMed] [Google Scholar]
  10. , , . Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt. Antimicrob Resist Infect Control. 2019;8:185.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , . Burden of carbapenem-resistant Acinetobacter baumannii harbouring blaOXA genes in the Indian intensive care unit. Glob J Med Pharm Biomed Update. 2023;18:12.
    [CrossRef] [Google Scholar]
  12. , , , . Antibiotic resistance profiles, molecular mechanisms and innovative treatment strategies of Acinetobacter baumannii. Microorganisms. 2020;8:935.
    [CrossRef] [PubMed] [Google Scholar]
  13. , , , , , , et al. A diverse panel of clinical Acinetobacter baumannii for research and development. Antimicrob Agents Chemother. 2020;64:e00840-20.
    [CrossRef] [PubMed] [Google Scholar]
  14. . Treatment Options for Carbapenem-Resistant Gram-Negative Bacterial Infections. Clin Infect Dis. 2019;69(Suppl 7):S565-75.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , . Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Microb Pathog. 2019;128:75-81.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , . Biofilm formation in Acinetobacter baumannii Genotype-phenotype correlation. Molecules. 2019;24:1849.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Antimicrobial activity of a repurposed harmine-derived compound on carbapenem-resistant Acinetobacter baumannii clinical isolates. Front Cell Infect Microbiol. 2022;11:789672.
    [CrossRef] [PubMed] [Google Scholar]
  18. , , , , , , et al. Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: A systemic review and Bayesian network meta-analysis. Crit Care. 2017;21:319.
    [CrossRef] [PubMed] [Google Scholar]
  19. , . Colistin resistance in Acinetobacter baumannii isolated from critically ill patients: Clinical characteristics, antimicrobial susceptibility and outcome. Afr Health Sci. 2019;19:2400-6.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , , . Indian medicinal plant extracts to control multidrug-resistant S. aureus including in biofilms. South Afr J Bot. 2020;128:283-91.
    [CrossRef] [Google Scholar]
  21. , , , , , . Plant extracts display synergism with different classes of antibiotics. An Acad Bras Ciênc. 2019;91:e20180117.
    [CrossRef] [PubMed] [Google Scholar]
  22. , , , . Essential oils, a new horizon in combating bacterial antibiotic resistance. Open Microbiol J. 2014;8:6-14.
    [CrossRef] [PubMed] [Google Scholar]
  23. . What are the Health Benefits of Cinnamon? . Medical News Today. Available from: https://www.medicalnewstoday.com/articles/266069 [Last accessed on 2022 Jul 15]
    [Google Scholar]
  24. , , , . Cinnamon from the selection of traditional applications to its novel effects on the inhibition of angiogenesis in cancer cells and prevention of Alzheimer's disease, and a series of functions such as antioxidant, anticholesterol, antidiabetes, antibacterial, antifungal, nematicidal, acaracidal, and repellent activities. J Tradit Complement Med. 2015;5:66-70.
    [CrossRef] [PubMed] [Google Scholar]
  25. , . Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014;2014:642942.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Phytochemical and pharmacological review of Cinnamomum verum J. Presl-a versatile spice used in food and nutrition. Food Chem. 2021;338:127773.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , , et al. Revisiting an ancient spice with medicinal purposes: Cinnamon. Trends Food Sci Technol. 2017;62:154-69.
    [CrossRef] [Google Scholar]
  28. , , , , , , et al. Cinnamomum species: Bridging phytochemistry knowledge, pharmacological properties and toxicological safety for health benefits. Front Pharmacol. 2021;12:600139.
    [CrossRef] [PubMed] [Google Scholar]
  29. , , , , , , et al. Inhibitory effect of cinnamon essential oils on selected cheese-contaminating fungi (Penicillium spp.) during the cheese-ripening process. Food Sci Biotechnol. 2014;23:1193-8.
    [CrossRef] [Google Scholar]
  30. , , , , , . Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine. Biomed Pharmacother. 2021;143:112221.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , . Evaluation of antimicrobial activity of cinnamaldehyde against carbapenem-resistant Acinetobacter baumannii nosocomial isolates. Int J Curr Microbiol Appl Sci. 2019;8:434-45.
    [CrossRef] [Google Scholar]
  32. , , , , , . In vitro antibacterial properties of Cinnamomum zeylanicum essential oil against clinical extensively drug-resistant bacteria. Eur J Integr Med. 2020;37:101146.
    [CrossRef] [Google Scholar]
  33. , , , , , , et al. Increasing antibiotic activity against a multidrug-resistant Acinetobacter spp. by essential oils of Citrus limon and Cinnamomum zeylanicum. Nat Prod Res. 2012;26:2235-8.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , , , . The biological activities of cinnamon, Geranium and lavender essential oils. Molecules. 2014;19:20929-40.
    [CrossRef] [PubMed] [Google Scholar]
  35. , , , , , , et al. Extraction of essential oils of Rosmarinus officinalis L. by two different methods: Hydrodistillation and microwave assisted hydrodistillation. ScientificWorldJournal. 2019;2019:3659432.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , . Trans-cinnamaldehyde and eugenol increase Acinetobacter baumannii sensitivity to beta-lactam antibiotics. Front Microbiol. 2018;9:1011.
    [CrossRef] [PubMed] [Google Scholar]
  37. , , , , , . Cinnamaldehyde: A plant-derived antimicrobial for overcoming multidrug-resistant Acinetobacter baumannii infection. Eur J Integr Med. 2021;48:101376.
    [CrossRef] [Google Scholar]
  38. , , , . Antibacterial and antibiofilm activity of cinnamaldehyde against carbapenem resistant Acinetobacter baumannii in Egypt: In vitro study. J Appl Pharm Sci. 2018;8:151-6.
    [CrossRef] [Google Scholar]
  39. , . Quorum sensing inhibitory and anti-Biofilm activity of essential oils and their in vivo efficacy in food systems. Food Biotechnol. 2014;28:269-92.
    [CrossRef] [Google Scholar]
  40. , . Antimicrobial activity of combined cinnamon nanoemulsions-antibiotics against Acinetobacter baumannii. Passer J Basic Appl Sci. 2019;1:8-11.
    [CrossRef] [Google Scholar]
  41. , . Ginger: The Genus Zingiber. In: Boca Raton. FL, USA: CRC Press; .
    [CrossRef] [Google Scholar]
  42. , , , , , , et al. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe) Foods. 2019;8:185.
    [CrossRef] [PubMed] [Google Scholar]
  43. , . Recent perspectives on the medicinal potential of ginger. Botanics Targets Ther. 2015;5:55-63.
    [CrossRef] [Google Scholar]
  44. , , , , , , et al. Ginger on human health: A comprehensive systematic review of 109 randomized controlled trials. Nutrients. 2020;12:157.
    [CrossRef] [PubMed] [Google Scholar]
  45. , , , , , , et al. Zingiber officinale (ginger) compounds have tetracycline-resistance modifying effects against clinical extensively drug-resistant Acinetobacter baumannii. Phytother Res. 2010;24:1825-30.
    [CrossRef] [PubMed] [Google Scholar]
  46. , , . Synergistic effect between Zingiber officinale volatile oil and meropenem against Acinetobacter baumannii producing-carbapenemase isolated from neurosurgery in Iraq. Syst Rev Pharm. 2020;11:920-5.
    [Google Scholar]
  47. , , , . Coriander (Coriandrum sativum): A promising functional food toward the well-being. Food Res Int. 2018;105:305-23.
    [CrossRef] [PubMed] [Google Scholar]
  48. , , , , , , et al. Antioxidant, antimicrobial and antibiofilm activity of coriander (Coriandrum sativum L.) essential oil for its application in Foods. Foods. 2020;9:282.
    [CrossRef] [PubMed] [Google Scholar]
  49. , , , . Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii. Phytomedicine. 2012;19:236-8.
    [CrossRef] [PubMed] [Google Scholar]
  50. , , , . Study of the major essential oil compounds of Coriandrum sativum against Acinetobacter baumannii and the effect of linalool on adhesion, biofilms and quorum sensing. Biofouling. 2016;32:155-65.
    [CrossRef] [PubMed] [Google Scholar]
  51. , , . In-depth pharmacological and nutritional properties of bael (Aegle marmelos): A critical review. J Agric Food Res. 2020;2:100081.
    [CrossRef] [Google Scholar]
  52. , , , , . Evaluation of relaxant effect in methanolic extract of Aegle marmelos on isolated sprague dawley bronchial tissue. Res J Pharm Technol. 2021;14:4241-6.
    [CrossRef] [Google Scholar]
  53. , , . Screening of herbal-based bioactive extract against carbapenem-resistant strain of Acinetobacter baumannii. Microb Drug Resist. 2016;22:364-71.
    [CrossRef] [PubMed] [Google Scholar]
  54. , , , . Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii. Microb Pathog. 2017;110:345-51.
    [CrossRef] [PubMed] [Google Scholar]
  55. , , . Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens. Front Microbiol. 2015;6:618.
    [CrossRef] [PubMed] [Google Scholar]
  56. . Study on genetic diversity between Origanum L. species based on genome size and ISSR markers. Ind Crops Prod. 2018;126:201-7.
    [CrossRef] [Google Scholar]
  57. , , , , , , et al. Origanum vulgare L. essential oil inhibits the growth of carbapenem-resistant gram-negative bacteria. Rev Soc Bras Med Trop. 2019;52:e20180502.
    [CrossRef] [PubMed] [Google Scholar]
  58. , , , , , , et al. Origanum vulgare essential oil: Antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii. Mol Biol Rep. 2020;47:9615-25.
    [CrossRef] [PubMed] [Google Scholar]
  59. , , , , , . Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii. J Ethnopharmacol. 2016;178:125-36.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
8,531

PDF downloads
467
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections

Suggested read for related articles:

© Copyright 2024 – Global Journal of Medical Pharmaceutical and Biomedical Update – All rights reserved.
Published by Scientific Scholar.

ISSN (Online): 2765-8910